This NDC is on FDA's drug shortage list (posted Apr 26, 2023)
Reported reason: Other
Product Information
BICILLIN L-A 2,400,000 UNITS is a brand product labeled by Pfizer Inc., priced at $182.5544 per ML under NDC 60793070210. Its NADAC has been published 339 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is BC.
Strength
2400000 [iU]/4mL
Manufacturer
Pfizer Inc.NDC
60793070210
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Effective Date
5/15/2025
Active Ingredients
PENICILLIN G BENZATHINEApproval Type
New Drug (NDA)
FDA Application
NDA050141FDA Approved
Before 1982
TE Code
BC
On Market Since
6/27/1952
Pharmacological Classes
Price Statistics
The NADAC for BICILLIN L-A 2,400,000 UNITS has been published 339 times since Nov 28, 2013, and over the history we have for it it has risen 507.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $182.5544 per ML |
|---|---|
| All-time high | $182.5544 (Nov 12, 2025) |
| All-time low | $30.0579 (Nov 28, 2013) |
| 52-week high | $182.5544 |
| 52-week low | $182.5544 |
| Median price | $64.7149 |
| Average price | $79.2144 |
| Largest weekly change | +94.6% (Jul 17, 2024) |
| Weeks tracked | 339 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+135.5%
5Y
+135.5%
All
+507.3%
Last surveyed Nov 12, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the penicillin G benzathine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
penicillin G benzathine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BICILLIN L-A 2,400,000 UNITS?
The current National Average Drug Acquisition Cost (NADAC) for BICILLIN L-A 2,400,000 UNITS, manufactured by Pfizer Inc., is $182.5544 per ML (NDC 60793070210), effective Nov 12, 2025.
How has the price of BICILLIN L-A 2,400,000 UNITS changed over time?
Over the history we have for it, the NADAC for BICILLIN L-A 2,400,000 UNITS has risen 507.3%. It has been tracked across 339 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BICILLIN L-A 2,400,000 UNITS?
Since Nov 28, 2013, the NADAC for BICILLIN L-A 2,400,000 UNITS has ranged from a low of $30.0579 (Nov 28, 2013) to a high of $182.5544 (Nov 12, 2025), with a median of $64.7149 per ML.
Are there cheaper alternatives to BICILLIN L-A 2,400,000 UNITS?
No other NADAC-published product currently shares the active ingredient and strength of BICILLIN L-A 2,400,000 UNITS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BICILLIN L-A 2,400,000 UNITS?
BICILLIN L-A 2,400,000 UNITS (NDC 60793070210) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Is BICILLIN L-A 2,400,000 UNITS in shortage?
Yes — NDC 60793070210 is currently listed in FDA's drug shortage database (posted Apr 26, 2023). Reported reason: Other.